We are an early stage synthetic protein company developing a disruptive, proprietary platform. Our technology industrializes on-demand engineering and non-ribosomal manufacturing of fully-functional proteins. Today, this platform empowers us to perform direct synthesis, in hours, of polypeptides of lengths exceeding 150 amino acids, including any number of non-natural chemical modifications.
Our protein products are poised to revolutionize drug discovery and development, serving as either therapeutics or as target antigens. We further offer superior durability, multi-functionality and immune-resistance properties by engineering, with site specific control, our molecules to contain non-natural amino acids, post translational modifications and conjugation handles. Alongside pursuit of an internal pipeline, we partner broadly with Bio-Pharma innovators in the peptide and biologics space.
Amide is at the forefront of a new industry—fully synthetic proteins—uniquely enabling the atom by atom engineering control of small molecules within the far more effective and specific biologics therapeutic class. As the experts in this new and exciting field, we bring an unparalleled series of innovations to the protein marketplace.